Previous close | 3.8400 |
Open | 3.8200 |
Bid | 3.8800 x 1400 |
Ask | 3.9300 x 1400 |
Day's range | 3.7250 - 4.0000 |
52-week range | 3.6200 - 8.0500 |
Volume | |
Avg. volume | 1,372,420 |
Market cap | 1.147B |
Beta (5Y monthly) | 0.36 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
VANCOUVER, British Columbia, April 08, 2024--AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
VANCOUVER, British Columbia, April 03, 2024--AbCellera (Nasdaq: ABCL) will announce its first quarter 2024 financial results on Tuesday, May 7, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.
VANCOUVER, British Columbia, March 19, 2024--AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Bloom Burton Healthcare Conference on Tuesday, April 16, 2024, at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time).